Loading...
Market
Will AlphaProteo win a major biotechnology award by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from major biotechnology award organizations
Story
Google DeepMind Unveils AlphaProteo for High-Strength Protein Binders with 3-300x Better Affinities
Sep 5, 2024, 03:24 PM
Google DeepMind has unveiled AlphaProteo, a new AI system designed to create novel, high-strength protein binders that target specific molecules. AlphaProteo achieves 3-300x better binding affinities and success rates on 7 targets compared to existing methods, making it a significant advancement in drug development, disease diagnosis, and biosensor technology. This system could accelerate the understanding of biological processes and aid in the development of new therapies. AlphaProteo's capabilities, trained on synthetic data from AlphaFold, are expected to outperform existing methods in binding proteins, potentially revolutionizing the field of biotechnology.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Highly Positive • 25%
Moderately Positive • 25%
Neutral • 25%
Negative • 25%
Drug Development • 25%
Agricultural Biotechnology • 25%
Industrial Enzymes • 25%
Other • 25%
0-10 • 25%
11-20 • 25%
21-30 • 25%
31 or more • 25%
Cancer • 25%
Autoimmune disorders • 25%
Infectious diseases • 25%
Other • 25%
0-1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%